Phase II trial of Pemetrexate (p) andd gemcitibine (G) as first line chemotherapy for elderly and/or poor performance status patients with IIIB-IV non small cell lung cancer (NSCLCA)

Paul R Kaywin

Phase II trial of Pemetrexate (p) andd gemcitibine (G) as first line chemotherapy for elderly and/or poor performance status patients with IIIB-IV non small cell lung cancer (NSCLCA)

Research output: Contribution to conference › Presentation

Original language	American English
State	Published - 2006
Event	American Society of Clinical Oncology Annual Meeting - Duration: Jun 2 2023 → …

Conference

Conference	American Society of Clinical Oncology Annual Meeting
Period	6/2/23 → …

Disciplines

Medicine and Health Sciences

Cite this

@conference{4bd9b11a2a7146be9128a6040a9026b3,

title = "Phase II trial of Pemetrexate (p) andd gemcitibine (G) as first line chemotherapy for elderly and/or poor performance status patients with IIIB-IV non small cell lung cancer (NSCLCA)",

author = "Kaywin, {Paul R}",

year = "2006",

language = "American English",

note = "American Society of Clinical Oncology Annual Meeting ; Conference date: 02-06-2023",

}